1Akira S,Mine K,Kuwabara Y,et al.Efficacy of long-term,low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis[J].Med Sci Monit,2009,15(1):CR1-4.
2JanickiTI.Treatment of the pelvic pain associated with endometriosis using danazol vaginal suppositories.Two year follow-up[J].Fertil Steri,2002,77(1):52-56.
3Park HJ,Koo YA,Yoon BK,et al.Postoperative long-term maintenance therapy with oral contraceptives after gonadotropin-releasing hormone analog treatment in women with ovarian endometrioma[J].Minim Invasive Gynecol,2009,16(1):34-39.
4Hefler LA,Grimm C,van Trotsenburg M,et al.Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis:a pilot study[J].Fertil Steril,2005,84(4):1033.
5Verma A,Konje JC.Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients[J].Eur J Obstet Gynecol Reprod Biol,2009,143(2):112-115.
6Kupker W,Felberbaum RE,Krapp M,et al.Use of GnRH antagonists in the treatment of endometriosis[J].Reprod Biomed Online,2002,5:12-16.
7Chwalisz K,Garg R,Brenner RM,et al.Selective progesterone receptor modulators (SPRMs):a novel therapeutic concept in endometriosis[J].Ann N Y Acad Sci,2002,955:373-388.
8Bahamondes L,Petta CA,Fernandes A,et al.Use of the levonorgestrel-releasing intrauterine system in women with endometriosis,chronic pelvic pain and dys-menorrhea.Contraception[J],2007,75:S134-139.
9Nishida M,Nasu K,Ueda T,et al.Endometriotic cells are resistant to interferon gamma-induced cell growth inhibition and apoptosis:a possible mechanism involved in the pathogenesis of endometriosis[J].Mol Hum Reprod,2005,11 (1):29-34.
同被引文献9
1Begum T, Chowdhury SR. Aetiology and pathogenesis of endometriosis-a review[J]. Mymensingh Med J, 2013,22 (1) :218-221.
2Howard FM. Surgical treatment of endometriosis[J]. Ob- stet Gynecol Clin North Am,2011,38(4).677-686.
